135 related articles for article (PubMed ID: 16781126)
1. Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation.
Shao Q; Rowe RC; York P
Eur J Pharm Sci; 2006 Aug; 28(5):394-404. PubMed ID: 16781126
[TBL] [Abstract][Full Text] [Related]
2. Comparison of neurofuzzy logic and decision trees in discovering knowledge from experimental data of an immediate release tablet formulation.
Shao Q; Rowe RC; York P
Eur J Pharm Sci; 2007 Jun; 31(2):129-36. PubMed ID: 17459671
[TBL] [Abstract][Full Text] [Related]
3. Advantages of neurofuzzy logic against conventional experimental design and statistical analysis in studying and developing direct compression formulations.
Landín M; Rowe RC; York P
Eur J Pharm Sci; 2009 Nov; 38(4):325-31. PubMed ID: 19716414
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of the predictive ability of artificial neural network (ANN) models: a comparison of three ANN programs and four classes of training algorithm.
Plumb AP; Rowe RC; York P; Brown M
Eur J Pharm Sci; 2005; 25(4-5):395-405. PubMed ID: 15893460
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous fuzzy logic networks: fundamentals and development studies.
Pedrycz W
IEEE Trans Neural Netw; 2004 Nov; 15(6):1466-81. PubMed ID: 15565774
[TBL] [Abstract][Full Text] [Related]
6. Minimisation of the capping tendency by tableting process optimisation with the application of artificial neural networks and fuzzy models.
Belic A; Skrjanc I; Bozic DZ; Karba R; Vrecer F
Eur J Pharm Biopharm; 2009 Sep; 73(1):172-8. PubMed ID: 19465122
[TBL] [Abstract][Full Text] [Related]
7. Investigation of an artificial intelligence technology--Model trees. Novel applications for an immediate release tablet formulation database.
Shao Q; Rowe RC; York P
Eur J Pharm Sci; 2007 Jun; 31(2):137-44. PubMed ID: 17452096
[TBL] [Abstract][Full Text] [Related]
8. Tuning neural and fuzzy-neural networks for toxicity modeling.
Mazzatorta P; Benfenati E; Neagu CD; Gini G
J Chem Inf Comput Sci; 2003; 43(2):513-8. PubMed ID: 12653515
[TBL] [Abstract][Full Text] [Related]
9. Modelling formulations using gene expression programming--a comparative analysis with artificial neural networks.
Colbourn EA; Roskilly SJ; Rowe RC; York P
Eur J Pharm Sci; 2011 Oct; 44(3):366-74. PubMed ID: 21903163
[TBL] [Abstract][Full Text] [Related]
10. Modelling drug dissolution from controlled release products using genetic programming.
Do DQ; Rowe RC; York P
Int J Pharm; 2008 Mar; 351(1-2):194-200. PubMed ID: 18053658
[TBL] [Abstract][Full Text] [Related]
11. Development of sustained release formulation of an antithrombotic drug and application of Fuzzy logic.
Tan C; Degim İT
Pharm Dev Technol; 2012; 17(2):242-50. PubMed ID: 21062232
[TBL] [Abstract][Full Text] [Related]
12. GFAM: evolving Fuzzy ARTMAP neural networks.
Al-Daraiseh A; Kaylani A; Georgiopoulos M; Mollaghasemi M; Wu AS; Anagnostopoulos G
Neural Netw; 2007 Oct; 20(8):874-92. PubMed ID: 17851035
[TBL] [Abstract][Full Text] [Related]
13. Comparing the performance of multilayer perceptrons networks and neuro-fuzzy systems for on-line inference of Bacillus megaterium cellular concentrations.
Nucci ER; Silva RG; Souza VR; Giordano RL; Giordano RC; Cruz AJ
Bioprocess Biosyst Eng; 2007 Nov; 30(6):429-38. PubMed ID: 17609985
[TBL] [Abstract][Full Text] [Related]
14. [A method for creating fuzzy neural-network models using the MATLAB package for biomedical applications].
Zhilin VV; Filist SA; Rakhim KA; Shatalova OV
Med Tekh; 2008; (2):15-8. PubMed ID: 18507134
[TBL] [Abstract][Full Text] [Related]
15. Analysis of pellet properties with use of artificial neural networks.
Mendyk A; Kleinebudde P; Thommes M; Yoo A; Szlęk J; Jachowicz R
Eur J Pharm Sci; 2010 Nov; 41(3-4):421-9. PubMed ID: 20659554
[TBL] [Abstract][Full Text] [Related]
16. Neurofuzzy systems for the prediction of outcome in acute lower gastrointestinal hemorrhage.
Tez M; Tez S
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):813. PubMed ID: 18617790
[No Abstract] [Full Text] [Related]
17. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
18. Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets.
Petrović J; Ibrić S; Betz G; Parojcić J; Durić Z
Eur J Pharm Sci; 2009 Sep; 38(2):172-80. PubMed ID: 19632323
[TBL] [Abstract][Full Text] [Related]
19. Pipelining of Fuzzy ARTMAP without matchtracking: correctness, performance bound, and Beowulf evaluation.
Castro J; Secretan J; Georgiopoulos M; DeMara R; Anagnostopoulos G; Gonzalez A
Neural Netw; 2007 Jan; 20(1):109-28. PubMed ID: 17145166
[TBL] [Abstract][Full Text] [Related]
20. Piecewise-linear neural networks and their relationship to rule extraction from data.
Holena M
Neural Comput; 2006 Nov; 18(11):2813-53. PubMed ID: 16999580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
